## **Core Concept**
Ramelteon is a melatonin receptor agonist used primarily for the treatment of insomnia characterized by difficulties with sleep initiation. The bioavailability of a drug is a pharmacokinetic property that refers to the fraction of an administered dose of unchanged drug that reaches the systemic circulation and is one of the principal pharmacokinetic properties.

## **Why the Correct Answer is Right**
The correct bioavailability of Ramelteon is approximately 83-100% when taken orally, indicating that it is almost completely absorbed into the bloodstream. This high bioavailability suggests that Ramelteon undergoes extensive absorption with minimal first-pass metabolism.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option suggests a bioavailability that is significantly lower than the known value for Ramelteon, which does not align with its pharmacokinetic profile.
- **Option B:** This option also suggests a lower bioavailability compared to the established value, which could mislead test-takers into choosing an incorrect answer.
- **Option D:** This option implies a bioavailability that is higher than the documented range for Ramelteon.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Ramelteon has a high bioavailability, which typically results in more predictable and consistent therapeutic effects. This characteristic is beneficial for drugs intended to induce sleep, as it allows for more reliable onset and duration of action.

## **Correct Answer:** . 83-100%